Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Jan 1;44(1):71-72.
doi: 10.1503/jpn.180087.

Clozapine-induced obsessive–compulsive symptoms: mechanisms and treatment

David D. Kim  1 , Alasdair M. Barr  1 , Randall F. White  1 , William G. Honer  1 , Ric M. Procyshyn  1
Affiliations
Case Reports

Clozapine-induced obsessive–compulsive symptoms: mechanisms and treatment

David D. Kim et al. J Psychiatry Neurosci. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

A. Barr has received grants from Bristol-Myers Squibb and the Canadian Institutes of Health Research. R. White has received consulting fees or sat on paid advisory boards for Janssen, Lundbeck and Otsuka and has received a grant from ThermoFisher/Affymetrix. W. Honer has received consulting fees or sat on paid advisory boards for the Canadian Agency for Drugs and Technology in Health, the Centre for Drug Research and Development, AlphaSights, In Silico (unpaid) and Otsuka/Lundbeck. R. Procyshyn has received consulting fees or sat on paid advisory boards for Janssen, Lundbeck and Otsuka; is on the speaker’s bureau for Janssen, Lundbeck and Otsuka; and has received grants from the Canadian Institutes of Health Research. D. Kim has no conflict of interest to declare.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bottas A, Cooke RG, Richter MA. Comorbidity and pathophysiology of obsessive-compulsive disorder in schizophrenia: is there evidence for a schizo-obsessive subtype of schizophrenia? J Psychiatry Neurosci. 2005;30:187–93. - PMC - PubMed
    1. Lykouras L, Alevizos B, Michalopoulou P. Obsessive-compulsive symptoms induced by atypical antipsychotics. A review of the reported cases. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27:333–46. - PubMed
    1. Schirmbeck F, Zink M. Clozapine-induced obsessive-compulsive symptoms in schizophrenia: a critical review. Curr Neuropharmacol. 2012;10:88–95. - PMC - PubMed
    1. Fernandez-Egea E, Worbe Y, Bernardo M, et al. Distinct risk factors for obsessive and compulsive symptoms in chronic schizophrenia. Psychol Med. 2018;19:1–8. - PMC - PubMed
    1. Fineberg NA, Brown A, Reghunandanan S, et al. Evidence-based pharmacotherapy of obsessive-compulsive disorder. Int J Neuropsychopharmacol. 2012;15:1173–91. - PubMed

Publication types

MeSH terms